On August 20, John B. Sanfilippo & Sons (NASDAQ:JBSS) reported a fiscal year that looked strong on paper and a fourth quarter that told a messier story. Full-year net sales hit $1.18 billion, a record, while fourth-quarter diluted earnings per share fell 38.3% to $0.71. Volume returned to growth for the first time in five quarters, even as margins took a hit from a supplier recall and rising input costs.
A Bar Business Ready To Scale
The full-year numbers back up the record label. Net sales climbed 6.2% to $1.18 billion, and diluted earnings per share rose 4.6% to $5.26, helped by higher selling prices and lighter inventory valuation adjustments. The company also kept its 15-year streak of shareholder payouts alive, declaring $3.50 per share in total 2026 dividends, including a 5.6% bump to the annual payout and a $1.05 special dividend, both paid September 9.
The more forward-looking story is capacity. Fourth-quarter volume grew 1.4% after five straight quarterly declines, and contract manufacturing volume jumped 12.6% on a new customer relationship. Fisher-branded snack and trail mix shipments rose 15% on expanded specialty retail and e-commerce placement. Management pointed to new high-speed bar manufacturing lines at its Elgin facility, expected to be fully operational by the second quarter of fiscal 2027, with a chewy bar line targeted for late October 2026, as the source of an estimated $300 million in incremental growth potential. New fig bar and protein bar products have already been commercialized, with more protein offerings expected by the third quarter of fiscal 2027.
Recalls And Rising Costs Bite
The quarter’s profitability tells the other side. Gross profit fell 9.5% to $44.1 million, and gross margin dropped to 15.7% from 18.1% a year earlier. A voluntary recall tied to third-party dried milk powder used in Southern Style Nuts products cost the company $2.7 million, and management also cited higher customer claims, higher snack bar ingredient costs, manufacturing inefficiencies, and higher freight expense. Input stock costs for raw nuts and dried fruit rose 12.1% on higher pecan and almond acquisition costs.
The volume picture was uneven beneath the surface. Southern Style Nuts shipments fell 27% because of the recall, Orchard Valley Harvest trail mix volume dropped 26% on category softness, and Fisher recipe nut volume fell 12% on slower grocery velocities. Commercial ingredients volume declined 5.4% on the timing of peanut crushing stock sales, and private label bar shipments slipped 3%, tracking a 5% decline across the private label bar category. CEO Jeffrey T. Sanfilippo warned that “significant external uncertainties remain, including tariffs, inflation, unpredictable commodity costs, and broader macroeconomic challenges” heading into fiscal 2027, a transition year in which he steps into the Executive Chairman role and Jasper Sanfilippo takes over as CEO in October 2026.
What The Market Is Pricing In
Hedge fund ownership of JBSS slipped from 21 funds in the prior quarter to 19 in the most recent one, a modest pullback rather than a rush for the exits. Short interest sits at 6.69% of float, enough to suggest a real bear camp has formed but not the kind of crowding that signals a squeeze setup. The stock trades at a forward P/E of 11.53 as of August 28, a multiple that does not appear to be pricing in much of the bar-expansion growth story management is pitching for fiscal 2027.
Where This Leaves Investors
The tension in this report is straightforward: a record top line and a stacked new-product pipeline sitting next to a quarter where margins got squeezed from several directions at once. For the growth story to play out, the new Elgin bar lines and protein offerings need to actually convert into the $300 million in sales management is targeting. For the skeptics, recall-driven cost spikes, declining volume in several legacy brands, and a leadership handoff arriving in the same year as major capacity additions are all reasons for caution. How fiscal 2027 volume and margins shake out will likely settle which case wins.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
Disclosure: None. Follow Insider Monkey on Google News.
